Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMITAL for oral mucositis in head and neck cancer
NCT01941992Phase 2Completed
- Sponsor
- Istituto Oncologico Veneto
- Start
- Dec 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Samital in oral mucositis (OM), sponsored by Istituto Oncologico Veneto. Started Dec 2012; status: completed.
02
Drugs
Samital
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT01941992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941992.